The Harvey Prize rewards excellence by recognizing breakthroughs in science and technology. The monetary Prize is a banner of recognition for men and women who have truly contributed to the progress of humanity. No less, however, the Prize is a source of inspiration. Serving as stimulus, the award urges scientists and scholars forward to further accomplishment.
The Harvey Prize is awarded annually in a variety of disciplines within the categories of Science & Technology and Human Health. The Harvey Prize has also been awarded for Contribution to Peace in the Middle East.
Harvey Prize winners are selected by a council of world-renowned scientists and experts in each field through a rigorous selection process. The Harvey Prize Council, comprised of the President of the Technion, one Vice-President, Dean of the Graduate School, two representatives of both the Israel National Academy of Science and the Technion Senate, reviews all nominations. The Council then makes recommendations, which are scrutinized by professional evaluation committees in the respective fields, and then to the Technion Senate Committee for Honorary Degrees and Prizes. Once the Harvey family and the American Technion Society (ATS) have been formally notified of the choice of finalists, the President of the Technion informs the awardees of their impending honor.
Only living individuals are eligible — the award is not given posthumously.
There are no nationality, age, or sex restrictions — candidates from anywhere in the world can be nominated.
Technion academic staff (including emeriti), and members of its Board of Governors, cannot be nominated.
Previous recipients of very high-profile international awards like the Nobel Prize or Wolf Prize are normally not eligible, unless the work cited in their nomination is distinct and represents a new accomplishment
Sponsor Institute/Organizations: Technion-Israel Institute of Technology
Sponsor Type: Corporate/Non-Profit
Address: Technion City, Haifa 3200003, Israel
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 15, 2026
$75,000
Affiliation: Technion-Israel Institute of Technology
Address: Technion City, Haifa 3200003, Israel
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.